1 |
Kluwe WM, Haseman JK, Huff JE. 1983. The carcinogenicity of di(2-ethylhexyl) phthalate (DEHP) in perspective. J Toxicol Environ Health 12: 159-169.
DOI
|
2 |
Kluwe WM. 1982. Overview of phthalate ester pharmacokinetics in mammalian species. Environ Health Perspect 45: 3-9.
DOI
|
3 |
United States Consumer Product Safety Commission (US CPSC). 1985. Chronic hazard advisory panel on di(2-ethylhexyl) phthalate (DEHP). Report to the United States Consumer Product Safety Commission. Washington, DC, USA.
|
4 |
Crocker JF, Safe SH, Acott P. 1988. Effects of chronic phthalate exposure on the kidney. J Toxicol Environ Health 23: 433-444.
DOI
|
5 |
Choi H, Kim DP, Nam HJ, Joo MJ, Ko TS. 2008. Report of DEHP in saltfarm. Korea Consumer Agency. Webpage: http://www.kca.go.kr/modules/board/list.jsp?menuNo=309&boardConfigNo=156&CategoryNo=&ctx=&pagesize=15&sk=boardTitle&sv=%BF%B0%C0%FC
|
6 |
Korea Food and Drug Administration. 2008. Food Standards Codex. Korean Food Industry Association, Seoul, Korea
|
7 |
International Agency for Research on Cancer (IARC). http://monographs.iarc.fr/ENG/Monographs/vol77/volume77.pdf
|
8 |
International Programme on Chemical Safety (IPCS). 1992. Environmental Health Criteria 131: Diethylhexyl Phthalate. World Health Organization, Geneva, Switzerland.
|
9 |
Takatori S, Okamoto Y, Kitagawa Y, Hori S, Izumi SI, Makino T, Nakazawa H. 2008. Simulated neonatal exposure to DEHP and MEHP from PVC enteral nutrition products. Int J Pharm 352: 139-145.
DOI
|
10 |
Biohazard Information Manual of Agriculture & Food. 2007. Hazard chemical substance. Phthalate. Ministry for Food, Agriculture, Forestry and Fisheries, Korea. p 244-246.
|
11 |
FDA. 1999. United States Food and Drug Administration. Blood Bag Inspections. Webpage: http://www.fda.gov/ora/inspect_ref/igs/blood.html [downloaded 28 April 1999]
|